| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.032 | 0.8 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |